Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism IRAK1 antagonists(Interleukin-1 receptor-associated kinase 1 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diffuse Large B-Cell Lymphoma | Preclinical | US | 18 Nov 2020 |